This information was published on 2025-05-13T10:03:17 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2445200 |
| (220) |
24 Apr 2024
|
| (500) |
Provisions of paragraph 44(3)(b) and/or Reg 4.15A(3)(b) applied.
|
| (511) (510) |
Class 5
Pharmaceutical preparations for the treatment of neurological disorders |
| (540) | NEUROBION |
| (550) | Word |
| (730) |
The Procter & Gamble Company
|
| (750) |
PHILLIPS ORMONDE FITZPATRICK
|
Find out more about publications on the About page.